Αποτελέσματα Αναζήτησης
Systemic lupus erythematosus (SLE) M32-. Type 1 Excludes. lupus erythematosus (discoid) (NOS) (L93.0) Clinical Information. A chronic, inflammatory, connective tissue disease that can affect many organs including the joints, skin, heart, lungs, kidneys, and nervous system.
- M32.9
Approximate Synonyms. Systemic lupus erythematosus; Systemic...
- M32.9
4 Αυγ 2023 · Introduction. Systemic lupus erythematosus (SLE) is a systemic autoimmune disease with multisystemic involvement. The condition has several phenotypes, with varying clinical presentations from mild mucocutaneous manifestations to multiorgan and severe central nervous system involvement.
10 Ιουν 2021 · A comparison and review of three sets of classification criteria for systemic lupus erythematosus for distinguishing systemic lupus erythematosus from pure mucocutaneous manifestations in the lupus disease spectrum
5 Δεκ 2020 · Rheumatology Key messages. Positive ANA is required for SLE classification and ANA remains an appropriate screening test. While SLE manifestations are extremely variable, the 24 items in 10 domains will classify most patients. For classification and diagnosis, symptoms should only count when there is no more likely alternative explanation.
Systemic lupus erythematosus is a chronic, multisystem, inflammatory disorder of autoimmune etiology, occurring predominantly in young women. Common manifestations may include arthralgias and arthritis, Raynaud syndrome, malar and other rashes, pleuritis or pericarditis, renal or central nervous system involvement, and autoimmune cytopenias.
Systemic lupus erythematous (SLE) is a chronic autoimmune inflammatory disease characterized by autoantibodies directed against numerous self-nuclear antigens. Due to the heterogeneous nature of lupus, it has been challenging to identify markers that are sensitive and specific enough for its diagnosis and monitoring.
5 Οκτ 2023 · Systemic lupus erythematosus (SLE) is a generalised disorder that can affect any system. Symptoms and signs may accumulate over time. The diagnosis is made using 2019 criteria recommended by the American College of Rheumatology and the European League Against Rheumatology.
